POSaBIT Systems Corp. used its third-quarter earnings call to make a case that its point-of-sale business, not its legacy licensing deal, is now carrying the company. For a cannabis retail technology vendor that built part of its early revenue base on a licensing arrangement now winding down to a smaller, per-terminal royalty, that distinction matters. The quarter showed real strength in software revenue and margins, alongside a sequential dip in adjusted EBITDA and a net loss that, while narrower, hasn't gone away.
Recurring Software Revenue Takes the Lead
Point-of-sale revenue climbed 39% year over year, and recurring POS revenue - stripped of one-time hardware sales - hit $967,000, up roughly 60% from the same period last year. That's the number dispensary technology vendors live and die by. Hardware sales are a one-time transaction; recurring software fees are the subscription-style revenue that gives a company like POSaBIT visibility into next quarter's books instead of guessing. Excluding the licensing contribution entirely, core revenue grew 8% year over year and 14% sequentially, which suggests the underlying retail software business is expanding on its own, not just riding a temporary contract.
Margins Improve, But the Licensing Wind-Down Is a Real Headwind
Gross margin expanded to 87% from 81% a year earlier, helped by cutting about $232,000 in old-model payment processing costs and a bigger mix of software revenue. Year-to-date, margin reached 90%, up from 67% last year - a jump that's hard to ignore. Here's the catch, though: gross margin actually fell 4% sequentially, because license support revenue, which carried no associated cost, declined as the contract shifted from a monthly royalty to a per-terminal structure. Licensing collections dropped from $1.5 million in Q2 to $864,000 in Q3. That's not a crisis, but it does mean the easy, high-margin money is tapering off, and POSaBIT's core operations will have to do more of the heavy lifting going forward.
Cash Flow and Debt Moves Suggest Financial Discipline
Operating cash flow reached $2.1 million year-to-date, up sharply from $305,000 in the prior-year period - a meaningful improvement for a company that still posted a net loss. Management also repaid $1 million on its Perga Capital Partners loan ahead of schedule, negotiating lower ongoing interest and pushing the term out to March 2030. That's a reasonable trade: less cash on hand today ($2.9 million versus $3.3 million at the start of the quarter) in exchange for cheaper, longer-dated debt. For a smaller cap company in cannabis fintech, where capital access is already constrained by federal banking restrictions tied to the plant's legal status, locking in better loan terms is a quietly important move.
AI Tools and Washington Market Position
POSaBIT leaned into its Washington State dominance as a platform for cross-selling, with its Brand Portal now live across most of the state's major cannabis brands - connecting retailers, producers and processors in something closer to real time. The company also rolled out an AI-powered MCP server letting merchants query their own POS data in plain language, plus a back-end portal refresh built with internal AI tools. Management says AI use is now daily across the staff, framed explicitly as a way to grow output without growing headcount at the same pace. Operating expenses, excluding foreign exchange, stayed flat quarter over quarter even as core revenue rose - an early sign of the kind of operating leverage that compliance-heavy, margin-squeezed cannabis retail vendors need to actually reach sustained profitability.
What It Means for Operators and Investors
For dispensary operators relying on POSaBIT's terminals, the quarter is a reasonable signal of vendor stability - improving cash generation and renegotiated debt terms reduce the risk of service disruption. For investors, the picture is mixed but directionally positive: positive adjusted EBITDA for another quarter, a narrower operating loss (down 76% to $123,000), and insider share purchases exceeding 2 million shares year-to-date all point toward confidence. The Board's review of capital allocation options - reinvestment, a dividend, or a potential go-private transaction - suggests management sees enough stability to start thinking beyond survival mode. The ongoing net loss and the fading licensing cushion remain the honest risks here, not hidden ones.